Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
57.7 CNY | +8.85% | +16.24% | +4.97% |
25.04. | Hangzhou Tigermed Consulting: Gewinnrückgang von 59% in Q1 | MT |
25.04. | Hangzhou Tigermed Consulting Co., Ltd berichtet über die Ergebnisse für das erste Quartal bis zum 30. März 2024 | CI |
ETFs investiert in Hangzhou Tigermed Consulting Co., Ltd
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,98% | 1 M€ | -9.86% | - | |
0,69% | 2 M€ | -16.59% | - | |
0,18% | 35 M€ | -5.85% | - | |
0,02% | 2 M€ | -.--% | ||
0,02% | 7 M€ | -.--% | - | |
0,02% | 4 M€ | -11.56% | ||
0,01% | 117 M€ | +1.11% | - | |
0,00% | 441 M€ | +4.60% | - | |
0,00% | 2 808 M€ | +5.90% | - | |
0,00% | 149 M€ | +2.17% | - | |
0,00% | 31 M€ | +3.50% | - | |
0,00% | 4 M€ | -4.41% | - | |
0,00% | 34 M€ | +6.71% | - | |
0,00% | 34 M€ | +2.14% | - | |
0,00% | 39 M€ | +3.67% | - | |
0,00% | 302 M€ | +3.80% | - | |
0,00% | 17 M€ | +1.44% | - | |
0,00% | 147 M€ | +4.88% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+4.97% | 6.44 Mrd. | |
+1.51% | 42.75 Mrd. | |
+49.22% | 41.61 Mrd. | |
+8.57% | 41.34 Mrd. | |
-12.36% | 26.59 Mrd. | |
+8.92% | 25.49 Mrd. | |
-25.13% | 18.12 Mrd. | |
+29.17% | 12.24 Mrd. | |
-3.12% | 11.76 Mrd. | |
+6.35% | 11 Mrd. |
- Börse
- Aktien
- 300347 Aktie
- ETFs Hangzhou Tigermed Consulting Co., Ltd